Compare WAY & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAY | BRKR |
|---|---|---|
| Founded | 1999 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.3B |
| IPO Year | 2024 | 2000 |
| Metric | WAY | BRKR |
|---|---|---|
| Price | $34.37 | $48.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 10 |
| Target Price | ★ $47.86 | $45.67 |
| AVG Volume (30 Days) | 1.6M | ★ 2.4M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | $1,039,842,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $15.31 | $3.61 |
| Revenue Next Year | $16.18 | $1.23 |
| P/E Ratio | $55.23 | ★ N/A |
| Revenue Growth | ★ 14.76 | 6.10 |
| 52 Week Low | $29.78 | $28.53 |
| 52 Week High | $48.11 | $64.64 |
| Indicator | WAY | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 38.45 | 69.19 |
| Support Level | $34.48 | $45.37 |
| Resistance Level | $35.64 | $48.84 |
| Average True Range (ATR) | 1.22 | 1.84 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 13.84 | 80.83 |
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.